A mouse study found that amphetamine-related accuracy gains depended on task timing. Making the pre-signal interval variable eliminated gains observed under the original conditions, showing why the same task label can conceal different drug effects.
Katz and colleagues trained mice to respond to illuminated locations for food reward in a five-choice serial reaction-time procedure. They compared d-amphetamine, methylphenidate and pentobarbital, then altered task conditions. One group received variable timing before the signal; another received a warning light. These were controlled animal experiments rather than clinical ADHD treatment trials.
Amphetamine and methylphenidate increased signal-detection accuracy under the original conditions, while pentobarbital did not. The stimulants did not produce the same gains when pre-signal timing became variable. Adding a warning stimulus did not appreciably alter the stimulant response. The result concerns an interaction between drug and task arrangement, not a universal improvement that appeared whenever attention was measured.
Variable timing changes vigilance requirements and other aspects of stimulus control. The manipulation therefore helps investigate what the task measures without making it a complete model of human attention. Methylphenidate is also a different drug from amphetamine and should not be relabeled as the same exposure. Findings from mice cannot establish an individual human dose or impairment threshold. The study’s value is demonstrating that details such as when a signal appears can determine whether an apparent cognitive benefit is observed. Translation requires matching those procedural demands rather than relying only on a shared test name.
See human–mouse comparison using a different continuous-performance task.